Document is current
Any future updates will be listed below
-
Authors
Simonen, Piia
Nylund, Lotta
Vartiainen, Erkki
Kovanen, Petri T.
Strandberg, Timo E.
Öörni, Katariina
Wester, Ingmar
Gylling, Helena
-
Funding
Funding for this research was provided by:
University of Helsinki
- License Information
-
More Information
Article History
Received: 24 April 2024
Accepted: 14 October 2024
First Online: 21 October 2024
Declarations
:
: Not applicable.
: P.S. and E.V. declare no conflicts of interest. L.N. and I.W. are employed by Raisio Group plc. and I.W. own shares in the company. P.T.K. has received consultancy fees, lecture honoraria, and/or travel fees from Amarin, Amgen, Novartis, Raisio Group, and Sanofi. He is also a co-inventor of a patent concerning LDL aggregation. T.E.S. has taken part in consultative work, research, and educational cooperation with several companies marketing cholesterol-lowering products. K.Ö. and P.T.K. are co-inventors of a patent concerning LDL aggregation. H.G. has taken part in educational and consultative collaboration regarding human cholesterol metabolism with Raisio Group plc. Raisio Group plc. had no role in the design or execution of the study or analysis of the data.
